Capecitabine Pellets

(Product under development)
Capecitabine PelletsCapecitabine (Xeloda, Roche) is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers.

Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil.

Available Form:
Capecitabine Pellets
Capecitabine Granules

Umang Pharmatech equipments used for production of Capecitabine Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Capecitabine Pellets
Systematic (IUPAC) Name
Capecitabine Pellets
Identifiers
Capecitabine Pellets
Chemical data
pentyl [1-(3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]carbamate
CAS number : 154361-50-9
ATC code : L01BC06
PubChem : CID 60953
DrugBank : APRD00203
ChemSpider : 54916
UNII : 6804DJ8Z9U
KEGG : D01223
ChEMBL : CHEMBL1773
Formula : C15H22FN3O6
Mol. mass : 359.35 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL